FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|December 31, 2006
Chlamydial Testing: Just “One More Swab”
Increase compliance with testing forasymptomatic chlamydial infectionby letting patients know that they arenot being “singled out”; screening isrecommended for all sexually activewomen aged 25 years and younger.
Advertisement
Increase compliance with testing forasymptomatic chlamydial infectionby letting patients know that they arenot being "singled out"; screening isrecommended for all sexually activewomen aged 25 years and younger.Also advise patients of the long-termsequelae of untreated chlamydial infections.Finally, reassure them thatthe test is just "one more swab" inaddition to the Pap smear.-- Sueane Hemmer Goodreau, NP
Ithaca, NY
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
Advertisement
Advertisement
Trending on Patient Care Online
1
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
2
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
3
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
4
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
5